Literature DB >> 17803654

Involvement of Escherichia coli in pathogenesis of xanthogranulomatous cholecystitis with scavenger receptor class A and CXCL16-CXCR6 interaction.

Seiko Sawada1, Kenichi Harada, Kumiko Isse, Yasunori Sato, Motoko Sasaki, Yasuharu Kaizaki, Yasuni Nakanuma.   

Abstract

Xanthogranulomatous cholecystitis (XGC) is characterized by the infiltration of numerous foamy macrophages. Bacterial infection is thought to be involved in the pathogenesis of XGC. Using XGC and cultured murine biliary epithelial cells (BEC), the participation of E. coli and the role of the scavenger receptor class A (SCARA), as well as chemokine(C-X-C motif) ligand 16 (CXCL16) and its receptor chemokine(C-X-C motif) receptor 6 (CXCR6), were examined in the pathogenesis of XGC. E. coli components and genes were detected in XGC on immunohistochemistry and polymerase chain reaction (PCR), respectively. SCARA-recognizing E. coli was found in foamy macrophages aggregated in xanthogranulomatous lesions. CXCL16, which functions as a membrane-bound molecule and soluble chemokine to induce adhesion and migration of CXCR6(+) cells, was detected on gallbladder epithelia, and CXCR6(+)/CD8(+) T cells and CXCR6(+)/CD68(+) macrophages were also accumulated. In cultured BEC, CXCL16 mRNA and secreted soluble CXCL16 were constantly detected and upregulated by treatment with E. coli and lipopolysaccharide through Toll-like receptor 4. These suggest that SCARA in macrophages is involved in the phagocytosis of E. coli followed by foamy changes and that bacterial infection causes the upregulation of CXCL16 in gallbladder epithelia, leading to the chemoattraction of macrophages via CXCL16-CXCR6 interaction and formation of the characteristic histology of XGC.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17803654     DOI: 10.1111/j.1440-1827.2007.02154.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  7 in total

Review 1.  Xanthogranulomatous cholecystitis: a European and global perspective.

Authors:  Matthew David Hale; Keith J Roberts; James Hodson; Nigel Scott; Maria Sheridan; Giles J Toogood
Journal:  HPB (Oxford)       Date:  2013-08-29       Impact factor: 3.647

2.  Xanthogranulomatous cholecystitis complicated with primary sclerosing cholangitis: report of a case.

Authors:  Akira Mori; Ryuichiro Doi; Yoshikuni Yonenaga; Shuichiro Nakabo; Shujiro Yazumi; Junya Nakaya; Fumihiko Kono; Toshiaki Manabe; Shinji Uemoto
Journal:  Surg Today       Date:  2010-07-30       Impact factor: 2.549

3.  Xanthogranulomatous gastritis associated with actinomycosis: report of a case presenting as a large submucosal mass.

Authors:  Shogo Tajima; Michihiko Waki; Akihiko Ohata; Kenji Koda; Yasuhiko Maruyama
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

4.  CXCR6 is a marker for protective antigen-specific cells in the lungs after intranasal immunization against Mycobacterium tuberculosis.

Authors:  Lian Ni Lee; Edward O Ronan; Catherine de Lara; Kees L M C Franken; Tom H M Ottenhoff; Elma Z Tchilian; Peter C L Beverley
Journal:  Infect Immun       Date:  2011-05-31       Impact factor: 3.441

5.  Cholangiopathy with respect to biliary innate immunity.

Authors:  Kenichi Harada; Yasuni Nakanuma
Journal:  Int J Hepatol       Date:  2011-08-11

6.  Outcomes of Xanthogranulomatous cholecystitis in laparoscopic era: A retrospective Cohort study.

Authors:  Abdul Rehman Alvi; Imran Jalbani; Ghulam Murtaza; Aamir Hameed
Journal:  J Minim Access Surg       Date:  2013-07       Impact factor: 1.407

7.  Ascariasis of gall bladder associated with xanthogranulomatous inflammation and cholelithiasis.

Authors:  Sanjay D Deshmukh; Gayatri S Pathak; Amrut V Ashturkar; Avinash R Joshi; Rahul R Shelke
Journal:  Trop Parasitol       Date:  2011-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.